News & Events
CTCs accurate predictor of chemotherapy resistance
Liquid biopsy tests before and during chemotherapy can accurately detect whether patients with prostate cancer are resistant to treatment…
New oral inhibitor improves pancreatic cancer treatment
Scientists have developed a new oral DPP inhibitor that, when used in combination with targeted immunotherapy, has shown promise…
Exciting update for North America customers
We are delighted to announce the launch of a brand-new branch office dedicated to serving the needs of RGCC…
Chemotherapy drugs open door to cancer cells
Chemotherapy drugs could enhance the spread of cancer beyond a primary tumour site, scientists have established. In tests, researchers…
How cancer cells evade the immune system
Mutations in cancer-suppressing genes that block cell growth may explain why some cancers evade the body’s immune system, scientists…
Molecular boost for cancer immunotherapies
Scientists have identified a new synthetic molecular code that could improve a patient’s response to an effective cancer treatment,…
Celebrating our inaugural virtual RGCC Gathering
Zug, Switzerland
RGCC Network doctors from across the world set their alarm clocks and tuned in for RGCC’s first ever virtual…
Researchers identify a key enzyme in tumours
Researchers have identified a key enzyme that cancerous tumours rely on to grow and spread within the body. Described…
ctDNA accurate at diagnosing rectal cancer relapse
Combining circulating tumour DNA (ctDNA) with magnetic resonance imaging (MRI) can more accurately predict the likelihood of locally advanced…
Measuring circulating tumour DNA can improve bladder cancer treatment
The presence of circulating tumour DNA (ctDNA) is a crucial biomarker for patients with bladder cancer (urothelial carcinoma) researchers…
Promising new immunotherapy for colorectal cancer patients
Patients with advanced colorectal cancer can benefit from treatment with advanced immunotherapy, known as immune checkpoint inhibitor PD-1/PD-L1, scientists…
New breast cancer therapy a step closer to clinical trials
An advanced cancer therapy developed by RGCC scientists has been categorised as a Cell Therapy Medicinal Product (CTMP) by the European…